Canadian Medication Cost Savings Associated with Combinatorial Pharmacogenomic Guidance for Psychiatric Medications
Julie-Anne Tanner,1,2 Lisa C Brown,3 Kunbo Yu,3 James Li,3 Bryan M Dechairo4 1Neurogenetics Section, Campbell Family Mental Health Research Institute, Centre for Addiction and Mental Health, University of Toronto, Department of Psychiatry, Toronto, ON, Canada; 2Assurex Health Ltd., Toronto, ON, Cana...
Main Authors: | Tanner JA, Brown LC, Yu K, Li J, Dechairo BM |
---|---|
Format: | Article |
Language: | English |
Published: |
Dove Medical Press
2019-12-01
|
Series: | ClinicoEconomics and Outcomes Research |
Subjects: | |
Online Access: | https://www.dovepress.com/canadian-medication-cost-savings-associated-with-combinatorial-pharmac-peer-reviewed-article-CEOR |
Similar Items
-
Clinical Application and Educational Training for Pharmacogenomics
by: Jason W. Guy, et al.
Published: (2020-09-01) -
Pharmacogenomic Biomarkers and Their Applications in Psychiatry
by: Heejin Kam, et al.
Published: (2020-11-01) -
Rural Community Perceptions and Interests in Pharmacogenomics
by: John Stegelmeier, et al.
Published: (2020-06-01) -
Pharmacogenomics In Pharmacy Practice: Current Perspectives
by: Elewa H, et al.
Published: (2019-11-01) -
Curriculum in Pharmacogenetics and Pharmacogenomics in the Colleges and Schools of Pharmacy in the United States
by: Adams, Laura, et al.
Published: (2009)